Source: ERJ Open Res, 7 (1) 00723-2020; 10.1183/23120541.00723-2020
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Henan Xin, Qi Jin, Lei Gao. Conditional expanding post-exposure prophylaxis: a potential new tool for tuberculosis control. ERJ Open Res, 7 (1) 00723-2020; 10.1183/23120541.00723-2020

Member's Comments

No comment yet.

Related content which might interest you: Cost-effectiveness of two latent tuberculosis infection screening strategies Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Evolution of the strategies for control and elimination of tuberculosis Source: Eur Respir Monogr 2018; 82: 36-61 Year: 2018 Evolution of TB control and elimination strategies Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Appreciation efficiency of standard and alternative antituberculosis preventive therapy in children from different tuberculosis infection sources Source: Eur Respir J 2006; 28: Suppl. 50, 28s Year: 2006 The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis Source: Eur Respir J 2012; 39: 626-634 Year: 2012 Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Source: Eur Respir J 2013; 42: 1449-1453 Year: 2013 The case for assessing the full value of new tuberculosis vaccines Source: Eur Respir J, 55 (3) 1902414; 10.1183/13993003.02414-2019 Year: 2020 From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections Source: International Congress 2017 – Scientific year in review Year: 2017 The WHO-recommended strategy of tuberculosis control: the new vision of DOTS Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news? Year: 2007 Latent tuberculosis infection: a new paradigm Source: International Congress 2019 – State of the art session: Respiratory infections Year: 2019 What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis Source: Eur Respir Monogr 2018; 82: 414-429 Year: 2018 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 569-571 Year: 2015 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 571-574 Year: 2015 Framework for the evaluation of new tests for tuberculosis infection Source: Eur Respir J, 58 (2) 2004078; 10.1183/13993003.04078-2020 Year: 2021 Effects of DOTS strategy on new confirmed tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 588s Year: 2006 Mobilising community networks for early identification of tuberculosis and treatment initiation in Cambodia: an evaluation of a seed-and-recruit model Source: ERJ Open Res, 6 (2) 00368-2019; 10.1183/23120541.00368-2019 Year: 2020 Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012